Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures

Shinichi Toyooka, Yasuro Fukuyama, Ignacio I. Wistuba, Melvyn S. Tockman, John D. Minna, Adi F. Gazdar

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Purpose: The FEZ1/LZTS1 (FEZ1) gene, located on chromosome 8p22 (8p22), was identified recently as a candidate tumor suppressor gene. Because loss of heterozygosity at 8p21-22 is a frequent event in lung cancers, we studied FEZ1 alteration in short-term cultures of resected lung cancer tumors and cell lines. Experimental Design: We examined FEZ1 expression in 17 non-small cell lung cancer (NSCLC), 19 small cell lung cancer (SCLC) cell lines, and 6 pairs of short-term cultures of resected NSCLCs and accompanying nonmalignant bronchial cells (NBECs) by reverse transcription-PCR and Western blotting. To investigate the mechanism for silencing, cells were cultured with 5-aza-2′-deoxycytidine or trichostatin A. We screened for genomic mutations by PCR-singlestrand conformational polymorphism. Results: Thirteen of 17 NSCLC (76%) and 3 of 19 SCLC (16%) of cell lines showed absent expression (P = 0.001). Of the paired NSCLC-NBEC cultures, 3 of 6 showed loss of expression in tumor cell cultures. In the cell lines retaining expression, the amplicon products in SCLCs were more intense than those of NSCLCs and NBECs. Expression of FEZ1 was not restored by 5-aza-2′-deoxycytidine and trichostatin A. Although FEZ1 expression was moderately correlated with loss of heterozygosity of specific microsatellite makers at 8p21-22 in NSCLC cell lines, it was strongly correlated to D8S261 and LPL loci in SCLC cell lines. No mutation was found within cording region of FEZ1 by PCR-single-strand conformational polymorphism. Conclusions: We found differential FEZ1 expression in NSCLC and SCLC cell lines, and the absent expression in 3 of 6 short-term cultures of NSCLC tumors. FEZ1 may be related to tumorigenesis of lung cancer.

Original languageEnglish
Pages (from-to)2292-2297
Number of pages6
JournalClinical Cancer Research
Volume8
Issue number7
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Non-Small Cell Lung Carcinoma
Lung Neoplasms
Cell Culture Techniques
decitabine
Small Cell Lung Carcinoma
Cell Line
trichostatin A
Genes
Loss of Heterozygosity
Polymerase Chain Reaction
Mutation
Tumor Cell Line
Tumor Suppressor Genes
Microsatellite Repeats
Reverse Transcription
Cultured Cells
Neoplasms
Carcinogenesis
Research Design
Chromosomes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Toyooka, S., Fukuyama, Y., Wistuba, I. I., Tockman, M. S., Minna, J. D., & Gazdar, A. F. (2002). Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. Clinical Cancer Research, 8(7), 2292-2297.

Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. / Toyooka, Shinichi; Fukuyama, Yasuro; Wistuba, Ignacio I.; Tockman, Melvyn S.; Minna, John D.; Gazdar, Adi F.

In: Clinical Cancer Research, Vol. 8, No. 7, 2002, p. 2292-2297.

Research output: Contribution to journalArticle

Toyooka, S, Fukuyama, Y, Wistuba, II, Tockman, MS, Minna, JD & Gazdar, AF 2002, 'Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures', Clinical Cancer Research, vol. 8, no. 7, pp. 2292-2297.
Toyooka S, Fukuyama Y, Wistuba II, Tockman MS, Minna JD, Gazdar AF. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. Clinical Cancer Research. 2002;8(7):2292-2297.
Toyooka, Shinichi ; Fukuyama, Yasuro ; Wistuba, Ignacio I. ; Tockman, Melvyn S. ; Minna, John D. ; Gazdar, Adi F. / Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. In: Clinical Cancer Research. 2002 ; Vol. 8, No. 7. pp. 2292-2297.
@article{edc9134669f04a7ea936758d09add351,
title = "Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures",
abstract = "Purpose: The FEZ1/LZTS1 (FEZ1) gene, located on chromosome 8p22 (8p22), was identified recently as a candidate tumor suppressor gene. Because loss of heterozygosity at 8p21-22 is a frequent event in lung cancers, we studied FEZ1 alteration in short-term cultures of resected lung cancer tumors and cell lines. Experimental Design: We examined FEZ1 expression in 17 non-small cell lung cancer (NSCLC), 19 small cell lung cancer (SCLC) cell lines, and 6 pairs of short-term cultures of resected NSCLCs and accompanying nonmalignant bronchial cells (NBECs) by reverse transcription-PCR and Western blotting. To investigate the mechanism for silencing, cells were cultured with 5-aza-2′-deoxycytidine or trichostatin A. We screened for genomic mutations by PCR-singlestrand conformational polymorphism. Results: Thirteen of 17 NSCLC (76{\%}) and 3 of 19 SCLC (16{\%}) of cell lines showed absent expression (P = 0.001). Of the paired NSCLC-NBEC cultures, 3 of 6 showed loss of expression in tumor cell cultures. In the cell lines retaining expression, the amplicon products in SCLCs were more intense than those of NSCLCs and NBECs. Expression of FEZ1 was not restored by 5-aza-2′-deoxycytidine and trichostatin A. Although FEZ1 expression was moderately correlated with loss of heterozygosity of specific microsatellite makers at 8p21-22 in NSCLC cell lines, it was strongly correlated to D8S261 and LPL loci in SCLC cell lines. No mutation was found within cording region of FEZ1 by PCR-single-strand conformational polymorphism. Conclusions: We found differential FEZ1 expression in NSCLC and SCLC cell lines, and the absent expression in 3 of 6 short-term cultures of NSCLC tumors. FEZ1 may be related to tumorigenesis of lung cancer.",
author = "Shinichi Toyooka and Yasuro Fukuyama and Wistuba, {Ignacio I.} and Tockman, {Melvyn S.} and Minna, {John D.} and Gazdar, {Adi F.}",
year = "2002",
language = "English",
volume = "8",
pages = "2292--2297",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures

AU - Toyooka, Shinichi

AU - Fukuyama, Yasuro

AU - Wistuba, Ignacio I.

AU - Tockman, Melvyn S.

AU - Minna, John D.

AU - Gazdar, Adi F.

PY - 2002

Y1 - 2002

N2 - Purpose: The FEZ1/LZTS1 (FEZ1) gene, located on chromosome 8p22 (8p22), was identified recently as a candidate tumor suppressor gene. Because loss of heterozygosity at 8p21-22 is a frequent event in lung cancers, we studied FEZ1 alteration in short-term cultures of resected lung cancer tumors and cell lines. Experimental Design: We examined FEZ1 expression in 17 non-small cell lung cancer (NSCLC), 19 small cell lung cancer (SCLC) cell lines, and 6 pairs of short-term cultures of resected NSCLCs and accompanying nonmalignant bronchial cells (NBECs) by reverse transcription-PCR and Western blotting. To investigate the mechanism for silencing, cells were cultured with 5-aza-2′-deoxycytidine or trichostatin A. We screened for genomic mutations by PCR-singlestrand conformational polymorphism. Results: Thirteen of 17 NSCLC (76%) and 3 of 19 SCLC (16%) of cell lines showed absent expression (P = 0.001). Of the paired NSCLC-NBEC cultures, 3 of 6 showed loss of expression in tumor cell cultures. In the cell lines retaining expression, the amplicon products in SCLCs were more intense than those of NSCLCs and NBECs. Expression of FEZ1 was not restored by 5-aza-2′-deoxycytidine and trichostatin A. Although FEZ1 expression was moderately correlated with loss of heterozygosity of specific microsatellite makers at 8p21-22 in NSCLC cell lines, it was strongly correlated to D8S261 and LPL loci in SCLC cell lines. No mutation was found within cording region of FEZ1 by PCR-single-strand conformational polymorphism. Conclusions: We found differential FEZ1 expression in NSCLC and SCLC cell lines, and the absent expression in 3 of 6 short-term cultures of NSCLC tumors. FEZ1 may be related to tumorigenesis of lung cancer.

AB - Purpose: The FEZ1/LZTS1 (FEZ1) gene, located on chromosome 8p22 (8p22), was identified recently as a candidate tumor suppressor gene. Because loss of heterozygosity at 8p21-22 is a frequent event in lung cancers, we studied FEZ1 alteration in short-term cultures of resected lung cancer tumors and cell lines. Experimental Design: We examined FEZ1 expression in 17 non-small cell lung cancer (NSCLC), 19 small cell lung cancer (SCLC) cell lines, and 6 pairs of short-term cultures of resected NSCLCs and accompanying nonmalignant bronchial cells (NBECs) by reverse transcription-PCR and Western blotting. To investigate the mechanism for silencing, cells were cultured with 5-aza-2′-deoxycytidine or trichostatin A. We screened for genomic mutations by PCR-singlestrand conformational polymorphism. Results: Thirteen of 17 NSCLC (76%) and 3 of 19 SCLC (16%) of cell lines showed absent expression (P = 0.001). Of the paired NSCLC-NBEC cultures, 3 of 6 showed loss of expression in tumor cell cultures. In the cell lines retaining expression, the amplicon products in SCLCs were more intense than those of NSCLCs and NBECs. Expression of FEZ1 was not restored by 5-aza-2′-deoxycytidine and trichostatin A. Although FEZ1 expression was moderately correlated with loss of heterozygosity of specific microsatellite makers at 8p21-22 in NSCLC cell lines, it was strongly correlated to D8S261 and LPL loci in SCLC cell lines. No mutation was found within cording region of FEZ1 by PCR-single-strand conformational polymorphism. Conclusions: We found differential FEZ1 expression in NSCLC and SCLC cell lines, and the absent expression in 3 of 6 short-term cultures of NSCLC tumors. FEZ1 may be related to tumorigenesis of lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=0035992406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035992406&partnerID=8YFLogxK

M3 - Article

C2 - 12114433

AN - SCOPUS:0035992406

VL - 8

SP - 2292

EP - 2297

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 7

ER -